























Case report: Synergetic effect of ischaemia and
increased vagal tone inducing ventricular
fibrillation in a patient with Brugada syndrome
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Background Brugada syndrome (BS) is a hereditary channelopathy associated with syncope, malignant ventricular arrhythmia,
and sudden cardiac death. Right ventricular ischaemia and BS have similar underlying substrates precipitating ven-
tricular tachycardia or fibrillation (VF).
...................................................................................................................................................................................................
Case summary A 72-year-old woman with BS and a stenosis on the proximal right coronary artery received several subsequent
implantable cardioverter-defibrillator shocks due to VF during an episode of extreme nausea with vomiting.
...................................................................................................................................................................................................
Discussion This case report emphasizes on the synergetic effect of mild ischaemia and increased vagal tone on the substrate
responsible for BS to create pathophysiological changes precipitating VF.
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Introduction
Brugada syndrome (BS) was first described in 1992 and is character-
ized by an accentuated J wave or ST-segment elevation in the right pre-
cordial leads (V1–V3), often followed by a negative T wave. It is
associated with life-threatening ventricular arrhythmias, syncope, and
sudden cardiac death (SCD).1 The typical electrocardiogram (ECG)
pattern as well as the clinical presentation may be variable over time
and can be modulated by temperature or hormonal changes, exercise,
ischaemia, increased vagal tone, and medications that interact with the
cardiac sodium channel or the autonomic nervous system.2–6
The SCN5A gene is the major gene responsible for BS, and it enco-
des the pore-forming a-subunit of the cardiac Nav1.5 voltage-gated
sodium channel. The amount of sodium channel current (INa) reduc-
tion and thus the risk to develop ventricular arrhythmia depends on
the type of mutation.7
This is the first case illustrating the impact of simultaneously occur-
ring ischaemia and increased vagal tone in a patient with BS carrying a
severe mutation.
Learning points
• Multiple factors are known to contribute to ventricular tachy-
cardia/ventricular fibrillation initiation in Brugada syndrome,
and there may be a synergetic effect when several precipitating
factors occur at the same time.
• Increased vagal tone plays an important role and has often
been underestimated.
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A 61-year-old Caucasian woman with a history of dyslipidaemia,
hypertension, smoking, and three syncopes had a routine electrocar-
diogram (ECG) taken previous to a scheduled operation. This ECG
showed a typical type 2 Brugada syndrome (BS) pattern, with a
saddleback shaped ST-T configuration and ST-segment elevation >_
1 mm in V2–V3 (Figure 1A,B). During a subsequent flecainide provoca-
tion test (Figure 1C,D), a typical coved type 1 configuration in V1–V2
was induced, diagnostic for BS. Her father and grandfather had syn-
copes after the age of 50 and 70. No other significant family history
had been reported. A single chamber implantable cardioverter-
defibrillator (ICD) was implanted to prevent SCD. Genetic testing
confirmed the diagnosis of BS, showing a G1743E mutation in exon
28B of the SCN5A gene on chromosome 3P21-24.
At the age of 72, she developed extreme nausea and vomiting dur-
ing household activities, accompanied by radiating chest pain to the
left arm. She went to bed and subsequently experienced six defibrilla-
tor shocks within 10 min time. It was not until the next morning that
she went to the hospital. At that moment, she was asymptomatic and
physical examination was completely normal. ICD interrogation
showed these six shocks to be appropriate therapy for ventricular
fibrillation (VF) during a baseline bradycardia with ventricular extra-
systoles (Figure 2). All shocks were successful, however with reoccur-
rence of VF following the first five shocks. Routine chest X-ray and
transthoracic echocardiography were normal. The resting ECG
showed a baseline type 1 BS pattern in the in V1–V2, a saddleback
shaped type 2 BS pattern in V3 and no signs of ischaemia (Figure 1E,F).
As troponin and creatine kinase-MB isoenzyme levels were increased
[0.48mg/L (0–0.02mg/L) and 35.7mg/L (0–4.6mg/L), respectively], the
chest pain in this patient with a high cardiovascular risk profile was
considered suspicious for unstable angina or non-ST elevation myo-
cardial infarction and therefore coronary angiography was per-
formed. This revealed a triple vessel disease with one critical stenosis
at the proximal-mid right coronary artery (RCA) for which direct
stenting (Xience V 2.5 mm  15 mm) was performed with excellent
result (Figure 3). Cardiac enzymes further decreased. No complica-
tions occurred during follow-up. Subsequent ECGs showed no signs
of any scar. She remained syncope and arrhythmia free during follow-
up. Unfortunately, she died from cancer a few years later.
Discussion
Ischaemia of the right ventricle and
currents
Several reports have been published concerning BS and concomitant
acute myocardial infarction (AMI) or ischaemia.2,8 It is shown that
right ventricular (RV) ischaemia and BS have similar underlying sub-
strates precipitating ventricular tachycardia/ventricular fibrillation
(VT/VF).2,9 Transient outward current (Ito) plays an essential role and
causes a notched appearance of the action potential (AP). This Ito-
mediated notch is most prominent in RV epicardial tissues, which
forms the basis for the RV nature of BS,10,11 and is responsible for a
transmural (TM) voltage gradient during ventricular activation that
has been shown to underlie the J-wave and J-point elevation on the
ECG.12 During ventricular repolarization, a heterogeneous loss of
the epicardial RV AP dome may result in both TM and epicardial dis-
persion of repolarization. This creates a vulnerable window which
serves as the substrate for phase 2 re-entry (P2R), responsible for
closely coupled ventricular extrasystoles initiating VT/VF.3,11 Because
Ito is much more prominent in the RV
12 and because a large epicardial
Ito is necessary for an all-or-none repolarization in order to have loss
of the epicardial AP dome, the incidence of primary VF is higher with
an AMI or ischaemia involving or having a border with the RV.3,13
Right ventricular ischaemia or AMI due to critical lesions in the prox-
imal RCA, particularly with right ventricular outflow tract involve-
ment, have been reported to result in ST-segment elevation, similar
to that in BS (Brugada phenocopy).2 This effect is secondary to a re-
duction in ICa and activation of IK-ATP during ischaemia. As in this case,
patients with BS may therefore be more prone to ischaemia-related
SCD.9
Genetics
SCN5A mutations may provide a genetic predisposition for
ischaemia-related acquired VF.14 G1743E, which confirmed the diag-
nosis of BS in this case, is a causal missense SCN5A mutation, located
between segments 5 and 6 of domain 4. Biophysical analysis associ-
ated mutant G1743E channels with a markedly reduced INa,
4 so the
presence of this mutation can be expected to also exacerbate
arrhythmogenesis in the setting of AMI.9
Autonomic imbalance
Brugada syndrome is characterized by an autonomic imbalance, due
to a decreased adrenergic tone, resulting in a predominant parasym-
pathetic tone.5 Acetylcholine is known to facilitate loss of AP dome
by suppressing ICa and/or increasing potassium currents,
5,9,11 pre-
dominantly located in the epicardium. When vagal tone further
increases, these epicardial ion currents are modulated even more,
resulting in a more pronounced TM and epicardial dispersion,
At age 57 Three brutal syncopes
At age 61 Routine electrocardiogram (ECG): type 2 ECG (saddle
back pattern)
Flecainide provocation test: type 1 ECG (coved type
pattern)
Implantable cardioverter-defibrillator (ICD) implanted
Genetic testing: G1743E mutation in SCN5A gene
At age 72 Nausea, vomiting, chest pain
6 appropriate ICD shocks (ventricular fibrillation)
Baseline type 1 ECG
Increased troponin and CKMB
Coronary angiography: critical stenosis in proximal
right coronary artery -> stenting.
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Figure 1 Subsequent electrocardiogram’s. Preoperative electrocardiogram (A,B) at the age of 61 showing an right bundle branch block-like pattern
in the right precordial leads with only a slight J-point elevation and negative T wave in V1, but a saddleback shaped ST-T configuration with segment
elevation >_ 1 mm in V2–V3, being a typical type 2 Brugada syndrome pattern. Flecainide provocation (C,D): the electrocardiogram pattern in the pre-
cordial leads recorded at baseline (C) was normal and 5 min after 50 mg flecainide injection (D) it changed into a typical type 1 coved ST-segment ele-
vation >_2 mm with a gradually descending terminal portion followed by a negative T wave in V1–V2, diagnostic of Brugada syndrome. In V3, we
observe an additional typical saddleback shaped ST-elevation. Electrocardiogram on administration the morning after chest pain and six appropriate
implantable cardioverter-defibrillator shocks (E,F) also showing a typical baseline type 1 Brugada syndrome pattern in two right precordial leads (V1–
V2) and a saddleback shaped pattern in V3. There were no negative T waves, nor typical ischaemia-related ST-segment changes. Right precordial
electrocardiogram tracings in Brugada syndrome may be concealed and dynamic as shown in A–C–F, in part due to changes in vasovagal tone.
Figure 2 Implantable cardioverter-defibrillator record (AtlasTMþ VR V-193, single chamber implantable cardioverter-defibrillator, St Jude
Medical): first of six ventricular fibrillation episodes recorded: note short-coupled ventricular extrasystoles, preceding ventricular fibrillation and the
implantable cardioverter-defibrillator shock terminating the arrhythmia.




























































..consistent with aggravation of ST-segment elevation and higher pro-
pensity for P2R. This partly explains why VT/VF in BS most often
occurs at rest, during sleep, following vagal stimuli, or use of antiar-
rhythmic or vagotonic agents.5 Changes in parasympathetic tone also
contribute to the dynamic aspect of the typical right precordial ECG
as shown in Figure 1A–C–F. Acute myocardial infarction and subse-
quent chest pain are mostly associated with increased sympathetic
tone. However, RV or inferior AMI/ischaemia may also be associated
with increased vagal tone6 as seen in our case (bradycardia, nausea,
vomiting), which would therefore be another additional factor
increasing the risk for VF in this patient.
Conclusion
We present a unique case of BS in association with a critical proximal
RCA lesion, illustrating that mild RV ischaemia and additional vagal
influences act synergistically with the substrate responsible for BS to
create ST segment elevation and precipitate re-entry and VF.
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